Related Experiment Video
Updated: Jun 8, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
In the ring with polycystic kidney disease--avoiding the knockout punch
Julie Adam1, Patrick J Pollard
1Henry Wellcome Building for Molecular Physiology, University of Oxford, Oxford, OX3 7BN, UK.
New models for autosomal dominant polycystic kidney disease (PKD) utilize partial or timed suppression of Pkd1. These approaches offer more accurate preclinical models for studying this inherited renal disease.
Area of Science:
- Nephrology
- Genetics
- Pathology
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder caused by mutations in PKD1 or PKD2 genes, leading to renal cysts and fibrosis.
- Current mouse models often fail to accurately replicate the complexity of human ADPKD, limiting research into cyst development and disease mechanisms.
Discussion:
- Recent studies introduce novel ADPKD models in mice using miRNA or inducible targeted recombination for partial or timed Pkd1 suppression.
- These refined models aim to more closely mimic the gradual onset and progression of human ADPKD, unlike traditional complete knockout models.
Key Insights:
- Partial or timed suppression of Pkd1 offers a more nuanced approach to modeling ADPKD.
- Advanced mouse models are crucial for understanding disease modifiers, cystogenesis pathways, and developing effective therapies for ADPKD.
Outlook:
- These improved preclinical models hold promise for advancing our understanding of ADPKD pathogenesis.
- Further research with these models could accelerate the development of targeted treatments for this significant renal disease.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

